Browse the corpus

REFERENCES “A Comparison of Antiarrhythmic-Drug Therapy With Implantable Defibrillators in Patients Resuscitated From Near-Fatal Ventricular Arrhythmias. The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators,” N Engl J Med , 1997, 337(22):1576-83. [PubMed 9411221 ] American Academy of Pediatrics Committee on Drugs, "Transfer of Drugs and Other Chemicals Into Human Milk," Pediatrics , 2001, 108(3):776-89. [PubMed 11533352 ] American Geriatrics Society 2012 Beers Criteria Update Expert Panel, "American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults," J Am Geriatr Soc , 2012, 60(4):616-31. [PubMed 22376048 ] Bink-Boelkens MT, “Pharmacologic Management of Arrhythmias,” Pediatr Cardiol , 2000, 21(6):508-15. [PubMed 11050274 ] Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al, “ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias--Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias),” Circulation , 2003, 108(15):1871-909. [PubMed 14557344 ] Boutitie F, Boissel JP, Connolly SJ, et al, “Amiodarone Interaction With Beta-Blockers: Analysis of the Merged EMIAT (European Myocardial Infarct Amiodarone Trial) and CAMIAT (Canadian Amiodarone Myocardial Infarction Trial) Databases. The EMIAT and CAMIAT Investigators,” Circulation , 1999, 99(17):2268-75. [PubMed 10226092 ] Cairns JA, Connolly SJ, Roberts G, et al, “Randomised Trial of Outcome After Myocardial Infarction in Patients With Frequent or Repetitive Ventricular Premature Depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators,” Lancet , 1997, 349(9053):675-82. [PubMed 9078198 ] Chalmers JR, Bobek MB, and Militello MA, “Visual Compatibility of Amiodarone Hydrochloride Injection With Various Intravenous Drugs,” Am J Health Syst Pharm , 2001, 58(6):504-6. [PubMed 11286148 ] Coumel P and Fidelle J, “Amiodarone in the Treatment of Cardiac Arrhythmias in Children: One Hundred Thirty-Five Cases,” Am Heart J , 1980, 100(6 Pt 2):1063-9. [PubMed 7446409 ]

Chalmers JR, Bobek MB, and Militello MA, “Visual Compatibility of Amiodarone Hydrochloride Injection With Various Intravenous Drugs,” Am J Health Syst Pharm , 2001, 58(6):504-6. [PubMed 11286148 ] Coumel P and Fidelle J, “Amiodarone in the Treatment of Cardiac Arrhythmias in Children: One Hundred Thirty-Five Cases,” Am Heart J , 1980, 100(6 Pt 2):1063-9. [PubMed 7446409 ] Dager WE, Sanoski CA, Wiggins BS, et al, “Pharmacotherapy Considerations in Advanced Cardiac Life Support,” Pharmacotherapy , 2006, 26(12):1703-29. [PubMed 17125434 ] Daoud EG, Strickberger SA, Man KC, et al, “Preoperative Amiodarone as Prophylaxis Against Atrial Fibrillation After Heart Surgery,” N Engl J Med , 1997, 337(25):1785-91. [PubMed 9400034 ] Deedwania PC, Singh BN, Ellenbogen K, et al, “Spontaneous Conversion and Maintenance of Sinus Rhythm by Amiodarone in Patients With Heart Failure and Atrial Fibrillation: Observations From the Veterans Affairs Congestive Heart Failure Survival Trial of Antiarrhythmic Therapy (CHF-STAT). The Department of Veterans Affairs CHF-STAT Investigators,” Circulation , 1998, 98(23):2574-9. [PubMed 9843465 ] Dorian P, Cass D, Schwartz B, et al, “Amiodarone as Compared With Lidocaine for Shock-Resistant Ventricular Fibrillation,” N Engl J Med , 2002, 346(12):884-90. [PubMed 11907287 ] Doval HC, Nul DR, Grancelli HO, et al, “Randomised Trial of Low-Dose Amiodarone in Severe Congestive Heart Failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina,” Lancet , 1994, 344(8921):493-8. [PubMed 7914611 ] “Effect of Prophylactic Amiodarone on Mortality After Acute Myocardial Infarction and in Congestive Heart Failure: Meta-analysis of Individual Data From 6500 Patients in Randomised Trials: Amiodarone Trials Meta-analysis Investigators,” Lancet , 1997, 350(9089):1417-24. [PubMed 9371164 ] Etheridge SP, Craig JE, and Compton SJ, “Amiodarone Is Safe and Highly Effective Therapy for Supraventricular Tachycardia in Infants,” Am Heart J , 2001, 141(1):105-10. [PubMed 11136494 ] Field JM, Hazinski MF, Sayre MR, et al, “Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122 (18 Suppl 3):640-56. [PubMed 20956217 ]

Etheridge SP, Craig JE, and Compton SJ, “Amiodarone Is Safe and Highly Effective Therapy for Supraventricular Tachycardia in Infants,” Am Heart J , 2001, 141(1):105-10. [PubMed 11136494 ] Field JM, Hazinski MF, Sayre MR, et al, “Part 1: Executive Summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122 (18 Suppl 3):640-56. [PubMed 20956217 ] Figa FH, Gow RM, Hamilton RM, et al, “Clinical Efficacy and Safety of Intravenous Amiodarone in Infants and Children,” Am J Cardiol , 1994, 74(6):573-7. [PubMed 8074040 ] Fuster V, Ryden LE, Cannom DS, et al, “ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation-Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society,” J Am Coll Cardiol , 2006, 48(4):854-906. [PubMed 16904574 ] Garson A Jr, Gillette PC, McVey P, et al, “Amiodarone Treatment of Critical Arrhythmias in Children and Young Adults,” J Am Coll Cardiol , 1984, 4(4):749-55. [PubMed 6384328 ] Gersh BJ, Maron BJ, Bonow RO, et al, “2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation , 2011, 124(24):e783-831. [PubMed 22068434 ] Goldschlager N, Epstein AE, Naccarelli G, et al, “Practical Guidelines for Clinicians Who Treat Patients With Amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology,” Arch Intern Med , 2000, 160(12):1741-8. [PubMed 10871966 ] Guarnieri T, Nolan S, Gottlieb SO, et al, “Intravenous Amiodarone for the Prevention of Atrial Fibrillation After Open Heart Surgery: The Amiodarone Reduction in Coronary Heart (ARCH) Trial,” J Am Coll Cardiol , 1999, 34(2):343-7. [PubMed 10440143 ] Hazinski MF, Samson R, and Schexnayder S, 2010 Handbook of Emergency Cardiovascular Care for Healthcare Providers , South Deerfield, MA: American Heart Association; 2010.

Guarnieri T, Nolan S, Gottlieb SO, et al, “Intravenous Amiodarone for the Prevention of Atrial Fibrillation After Open Heart Surgery: The Amiodarone Reduction in Coronary Heart (ARCH) Trial,” J Am Coll Cardiol , 1999, 34(2):343-7. [PubMed 10440143 ] Hazinski MF, Samson R, and Schexnayder S, 2010 Handbook of Emergency Cardiovascular Care for Healthcare Providers , South Deerfield, MA: American Heart Association; 2010. Hillis LD, Smith PK, Anderson JL, et al, “2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation , 2011, 124(23):2610-42. [PubMed 22064600 ] Julian DG, Camm AJ, Frangin G, et al, “Randomised Trial of Effect of Amiodarone on Mortality in Patients With Left-Ventricular Dysfunction After Recent Myocardial Infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators,” Lancet , 1997, 349(9053):667-74. [PubMed 9078197 ] Kennedy RL, Griffiths H, Gray TA, et al, “Amiodarone and the Thyroid,” Clin Chem , 1989, 35(9):1882-7. [PubMed 2673586 ] Kleinman ME, Chameides L, Schexnayder SM, et al, “Part 14: Pediatric Advanced Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122(18 Suppl 3):876-908. [PubMed 20956230 ] Kowey PR, Levine JH, Herre JM, et al, “Randomized, Double-Blind Comparison of Intravenous Amiodarone and Bretylium in the Treatment of Patients With Recurrent, Hemodynamically Destabilizing Ventricular Tachycardia or Fibrillation,” Circulation , 1995, 92(11):3255-63. [PubMed 7586312 ] Kudenchuk PJ, Cobb LA, Copass MK, et al, “Amiodarone for Resuscitation After Out-of-Hospital Cardiac Arrest Due to Ventricular Fibrillation,” N Engl J Med , 1999, 341(12):871-8. [PubMed 10486418 ] Martino E, Bartalena L, Bogazzi, et al, “The Effects of Amiondarone on the Thyroid,” Endocr Rev , 2001, 22(2):240-54. [PubMed 11294826 ] Massie BM, Fisher SG, Radford M, et al, “Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure. CHF-STAT Investigators,” Circulation , 1996, 93(12):2128-34. [PubMed 8925581 ] McKee MR, “Amiodarone - An “Old” Drug With New Recommendations,” Curr Opin Pediatr , 2003, 15(2):193-9. [PubMed 12640278 ]

Massie BM, Fisher SG, Radford M, et al, “Effect of Amiodarone on Clinical Status and Left Ventricular Function in Patients With Congestive Heart Failure. CHF-STAT Investigators,” Circulation , 1996, 93(12):2128-34. [PubMed 8925581 ] McKee MR, “Amiodarone - An “Old” Drug With New Recommendations,” Curr Opin Pediatr , 2003, 15(2):193-9. [PubMed 12640278 ] Munoz A, Karila P, Gallay P, et al, “A Randomized Hemodynamic Comparison of Intravenous Amiodarone With and Without Tween 80,” Eur Heart J , 1988, 9(2):142-8. [PubMed 3280316 ] Neumar RW, Otto CW, Link MS, et al, “Part 8: Adult Advanced Cardiovascular Life Support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care,” Circulation , 2010, 122(18 Suppl 3):729-67. Ott MC, Khoor A, Leventhal JP, et al, “Pulmonary Toxicity in Patients Receiving Low-Dose Amiodarone,” Chest , 2003, 123(2):646-54. [PubMed 12576397 ] Paul T and Guccione P, “New Antiarrhythmic Drugs in Pediatric Use: Amiodarone,” Pediatr Cardiol , 1994, 15(3):132-8. [PubMed 8047495 ] Paul T, Bertram H, Bokenkamp R, et al, “Supraventricular Tachycardia in Infants, Children and Adolescents: Diagnosis, and Pharmacological and Interventional Therapy,” Paediatr Drugs , 2000, 2(3):171-81. [PubMed 10937468 ] Perry JC, Fenrich AL, Hulse JE, et al, “Pediatric Use of Intravenous Amiodarone: Efficacy and Safety in Critically Ill Patients From a Multicenter Protocol,” J Am Coll Cardiol , 1996, 27(5):1246-50. [PubMed 8609351 ] Phillips MS, “Standardizing I.V. Infusion Concentrations: National Survey Results,” Am J Health Syst Pharm , 2011, 68(22):2176-82. [PubMed 22058104 ] Raja P, Hawker RE, Chaikitpinyo A, et al, “Amiodarone Management of Junctional Ectopic Tachycardia After Cardiac Surgery in Children,” Br Heart J , 1994, 72(3):261-5. [PubMed 7946778 ] Reiffel JA and Kowey PR, "Generic Antiarrhythmics Are not Therapeutically Equivalent for the Treatment of Tachyarrhythmias," Am J Cardiol , 2000, 85(9):1151-3, A10. [PubMed 10781771 ] Roy D, Talajic M, Dorian P, et al, “Amiodarone to Prevent Recurrence of Atrial Fibrillation. Canadian Trial of Atrial Fibrillation Investigators,” N Engl J Med , 2000, 342(13):913-20. [PubMed 10738049 ] Sauro SC, DeCarolis DD, Pierpont GL, et al, "Comparison of Plasma Concentrations for Two Amiodarone Products," Ann Pharmacother , 2002, 36(11):1682-5. [PubMed 12398559 ]

Roy D, Talajic M, Dorian P, et al, “Amiodarone to Prevent Recurrence of Atrial Fibrillation. Canadian Trial of Atrial Fibrillation Investigators,” N Engl J Med , 2000, 342(13):913-20. [PubMed 10738049 ] Sauro SC, DeCarolis DD, Pierpont GL, et al, "Comparison of Plasma Concentrations for Two Amiodarone Products," Ann Pharmacother , 2002, 36(11):1682-5. [PubMed 12398559 ] Shahar E, Barzilay Z, Frand M, et al, “Amiodarone in Control of Sustained Tachyarrhythmias in Children With Wolff-Parkinson-White Syndrome,” Pediatrics , 1983, 72(6):813-6. [PubMed 6646922 ] Shuler CO, Case CL, and Gillette PC, “Efficacy and Safety of Amiodarone in Infants,” Am Heart J , 1993, 125(5 Pt 1):1430-2. [PubMed 8480599 ] Singh SN, Fletcher RD, Fisher SG, et al, “Amiodarone in Patients With Congestive Heart Failure and Asymptomatic Ventricular Arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure,” N Engl J Med , 1995, 333(2):77-82. [PubMed 7539890 ] Skanes AC, Healey JS, Cairns JA, et al, “Focused 2012 Update of the Canadian Cardiovascular Society Atrial Fibrillation Guidelines: Recommendations for Stroke Prevention and Rate/Rhythm Control,” Can J Cardiol , 2012, 28(2):125-36. [PubMed 22433576 ] Skrifvars MB, Kuisma M, Boyd J, et al, “The Use of Undiluted Amiodarone in the Management of Out-of Hospital Cardiac Arrest,” Acta Anaesthesiol Scand , 2004, 48(5):582-7. [PubMed 15101852 ] Soult JA, Munoz M, Lopez JD, et al, “Efficacy and Safety of Intravenous Amiodarone for Short-Term Treatment of Paroxysmal Supraventricular Tachycardia in Children,” Pediatr Cardiol , 1995, 16(1):16-9. [PubMed 7753695 ] Stamou SC, Hill PC, Sample GA, et al, “Prevention of Atrial Fibrillation After Cardiac Surgery: The Significance of Postoperative Oral Amiodarone,” Chest , 2001, 120(6):1936-41. [PubMed 11742925 ] Trip MD, Wiersinga W, and Plomp TA, “Incidence, Predictability, and Pathogenesis of Amiodarone-Induced Thyrotoxicosis and Hypothyroidism,” Am J Med 1991, 91(5):507-11. [PubMed 1951413 ] Vorperian VR, Havighurst TC, Miller S, et al, “Adverse Effects of Low Dose Amiodarone: A Meta-analysis,” J Am Coll Cardiol , 1997, 30(3):791-8. [PubMed 9283542 ]

Trip MD, Wiersinga W, and Plomp TA, “Incidence, Predictability, and Pathogenesis of Amiodarone-Induced Thyrotoxicosis and Hypothyroidism,” Am J Med 1991, 91(5):507-11. [PubMed 1951413 ] Vorperian VR, Havighurst TC, Miller S, et al, “Adverse Effects of Low Dose Amiodarone: A Meta-analysis,” J Am Coll Cardiol , 1997, 30(3):791-8. [PubMed 9283542 ] Wann SL, Curtis AB, January CT, et al, “2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Updating the 2006 Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines,” Circulation , 2011, 123 (1):104-23. [PubMed 21173346 ] Zimetbaum P, “Amiodarone for Atrial Fibrillation,” N Engl J Med , 2007, 356(9):935-41. [PubMed 17329700 ] Zipes DP, Camm AJ, Borggrefe M, et al, “ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death),” J Am Coll Cardiol , 2006, 48(5):247-346. [PubMed 16949478 ] Topic 8595 Version 53.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.6- C21.56 Licensed to: AsanBook Dig. Med. Lib. | Support Tag: [0604-61.234.146.186-93025ABAAB-S244013.14]